Autor(es)

Valente, Leticia Cardoso ; Bacil, Gabriel Prata ; Riechelmann-Casarin, Luana ; Barbosa, Giullia Cavichiolli ; Barbisan, Luis Fernando ; Romualdo, Guilherme Ribeiro

• Tipo de documento: Artigo Científico
• Fonte: Life Sciences; v. 351, p. 13-pg., 2024-06-13.

Resumo

The hepatocellular carcinoma (HCC) features a remarkable epidemiological burden, ranking as the third most lethal cancer worldwide. As the HCC-related molecular and cellular complexity unfolds as the disease progresses, the use of a myriad of in vitro models available is mandatory in translational preclinical research setups. In this review paper, we will compile cutting-edge information on the in vitro bioassays for HCC research, (A) emphasizing their morphological and molecular parallels with human HCC; (B) delineating the advantages and limitations of their application; and (C) offering perspectives on their prospective applications. While bidimensional (2D) (co) culture setups provide a rapid low-cost strategy for metabolism and drug screening investigations, tridimensional (3D) (co) culture bioassays - including patient-derived protocols as organoids and precision cut slices - surpass some of the 2D strategies limitations, mimicking the complex microarchitecture and cellular and non-cellular microenvironment observed in human HCC. 3D models have become invaluable tools to unveil HCC pathophysiology and targeted therapy. In both setups, the recapitulation of HCC in different etiologies/backgrounds (i.e., viral, fibrosis, and fatty liver) may be considered as a fundamental guide for obtaining translational findings. Therefore, a "multimodel" approach - encompassing the advantages of different in vitro bioassays - is encouraged to circumvent "model-biased" outcomes in preclinical HCC research. (AU)

• Processo FAPESP: 22/13402-9 - Efeitos dos aditivos alimentares carboximetilcelulose e polissorbato 80 sobre o processo de hepatocarcinogênese associada à doença hepática gordurosa não-alcoólica
• Beneficiário: Gabriel Bacil Prata
• Modalidade de apoio: Bolsas no Brasil - Doutorado
• Processo FAPESP: 23/05411-0 - Efeitos da combinação de compostos do café e agentes antitumorais sobre o carcinoma hepatocelular: Investigação in vitro e in vivo
• Beneficiário: Leticia Cardoso Valente
• Modalidade de apoio: Bolsas no Brasil - Doutorado
• Processo FAPESP: 23/08751-7 - Multimodel Drug Screening Platform (MDSP): Insights pré-clínicos e moleculares para o gerenciamento dos cânceres de cólon e fígado.
• Beneficiário: Guilherme Ribeiro Romualdo
• Modalidade de apoio: Bolsas no Brasil - Projeto Geração
• Processo FAPESP: 22/16633-1 - Carboximetilcelulose e Polissorbato 80: Efeitos de aditivos alimentares sobre a hepatocarcinogênese associada à doença hepática não alcoólica.
• Beneficiário: Luís Fernando Barbisan
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 23/17585-3 - O Ácido Cafeico promove a resposta antitumoral do Sorafenibe sobre o Carcinoma Hepatocelular? Uma abordagem in vitro
• Beneficiário: Luana Riechelmann Casarin
• Modalidade de apoio: Bolsas no Brasil - Iniciação Científica